Oyp. Hu et al., PHARMACOKINETICS OF FOSINOPRILAT IN CHINESE AND WHITES AFTER INTRAVENOUS ADMINISTRATION, Journal of clinical pharmacology, 37(9), 1997, pp. 834-840
The pharmacokinetics of fosinoprilat was studied in 12 healthy Chinese
men after a 7.5 mg intravenous dose of fosinoprilat. The data were co
mpared with those from an earlier study using the same protocol in nin
e healthy white men. Blood and urine samples were obtained before and
at various time intervals after fosinoprilat administration up to 24 h
ours and 48 hours, respectively. Pharmacokinetic parameters were calcu
lated by fitting the plasma or serum concentrations to a three-compart
ment model. The total clearance (Cl-t), renal clearance (Cl-T), and no
nrenal clearance (Cl-NR) were significantly lower in Chinese (16.29 +/
- 6.92, 6.85 +/- 2.97, and 9.44 +/- 5.08 mL.hr(-1).kg(-1)). The Chines
e subjects had a significantly lower volume of distribution (V-c [volu
me of distribution of central compartment] and Vd(ss) [volume of distr
ibution at steady state]) (29.38 +/- 21.12 and 73.67 +/- 40.20 mL/kg)
than white men (58.14 +/- 15.01 and 152.01 and 152.49 +/- 24.89 mL/kg)
. The Chinese men also had a shorter elimination half-life than whites
, although not statistically significant. The respective half-lives in
Chinese and whites were 5.51 +/- 1.53 and 8.24 +/- 4.99 hours. The si
gnificant differences in Cl-NR and Cl-R may be related to lower liver
elimination function and lower kidney excretory function, respectively
. Plasma protein binding may contribute to part of the difference in t
he volume of distribution. Chinese men have smaller volume of distribu
tion and clearances of fosinoprilat after intravenous administration c
ompared with white men. The cumulative urine excretion of fosinoprilat
was not different between Chinese and whites. Chinese may require a l
ower fosinoprilat dosage to obtain plasma concentrations similar to wh
ites after intravenous administration. However, since a relatively hig
h variation was found in fosinopril oral absorption, the oral dosage o
f fosinopril in Chinese and whites may not be different. Further study
is obviously needed to elucidate whether the pharmacodynamic effect m
ay be different between Chinese and whites.